| Dr Mark W Mulkey, MD | |
|
250 S Crescent Dr, Mason City, IA 50401-2926 | |
| (641) 494-5360 | |
| (641) 494-5361 |
| Full Name | Dr Mark W Mulkey |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 38 Years |
| Location | 250 S Crescent Dr, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700872777 | NPI | - | NPPES |
| 0051565 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 26755 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures, SV Life Sciences and Versant Ventures.
The Obama administration told the Supreme Court on Friday that nearly all of President Barack Obama's healthcare overhaul can survive if the court declares unconstitutional the law's centerpiece provision requiring health coverage. Administration attorneys argued in a written brief that all but two provisions can be separated from the requirement that Americans buy health insurance or pay a penalty by 2014, the law's cornerstone known as the individual mandate.
Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug application (IND) to commence clinical trials advancing the development of NRL-1 for the treatment of acute breakthrough seizures.
The Canadian Institutes of Health Research (CIHR) and the Canadian Medical Association Journal (CMAJ) today honoured eight outstanding Canadian individuals and teams with the first ever CIHR-CMAJ Top Canadian Achievements in Health Research Awards, which recognize and celebrate Canadian health research and innovation excellence.
Young people overwhelmingly support putting tobacco products out of sight in shops according to new research released today (Monday) by Cancer Research UK.
› Verified 1 days ago
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures, SV Life Sciences and Versant Ventures.
The Obama administration told the Supreme Court on Friday that nearly all of President Barack Obama's healthcare overhaul can survive if the court declares unconstitutional the law's centerpiece provision requiring health coverage. Administration attorneys argued in a written brief that all but two provisions can be separated from the requirement that Americans buy health insurance or pay a penalty by 2014, the law's cornerstone known as the individual mandate.
Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug application (IND) to commence clinical trials advancing the development of NRL-1 for the treatment of acute breakthrough seizures.
The Canadian Institutes of Health Research (CIHR) and the Canadian Medical Association Journal (CMAJ) today honoured eight outstanding Canadian individuals and teams with the first ever CIHR-CMAJ Top Canadian Achievements in Health Research Awards, which recognize and celebrate Canadian health research and innovation excellence.
Young people overwhelmingly support putting tobacco products out of sight in shops according to new research released today (Monday) by Cancer Research UK.
› Verified 1 days ago
| Entity Name | Mason City Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043254055 PECOS PAC ID: 2860385572 Enrollment ID: O20040205001159 |
News Archive
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures, SV Life Sciences and Versant Ventures.
The Obama administration told the Supreme Court on Friday that nearly all of President Barack Obama's healthcare overhaul can survive if the court declares unconstitutional the law's centerpiece provision requiring health coverage. Administration attorneys argued in a written brief that all but two provisions can be separated from the requirement that Americans buy health insurance or pay a penalty by 2014, the law's cornerstone known as the individual mandate.
Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug application (IND) to commence clinical trials advancing the development of NRL-1 for the treatment of acute breakthrough seizures.
The Canadian Institutes of Health Research (CIHR) and the Canadian Medical Association Journal (CMAJ) today honoured eight outstanding Canadian individuals and teams with the first ever CIHR-CMAJ Top Canadian Achievements in Health Research Awards, which recognize and celebrate Canadian health research and innovation excellence.
Young people overwhelmingly support putting tobacco products out of sight in shops according to new research released today (Monday) by Cancer Research UK.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark W Mulkey, MD 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 494-5360 | Dr Mark W Mulkey, MD 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 494-5360 |
News Archive
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures, SV Life Sciences and Versant Ventures.
The Obama administration told the Supreme Court on Friday that nearly all of President Barack Obama's healthcare overhaul can survive if the court declares unconstitutional the law's centerpiece provision requiring health coverage. Administration attorneys argued in a written brief that all but two provisions can be separated from the requirement that Americans buy health insurance or pay a penalty by 2014, the law's cornerstone known as the individual mandate.
Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug application (IND) to commence clinical trials advancing the development of NRL-1 for the treatment of acute breakthrough seizures.
The Canadian Institutes of Health Research (CIHR) and the Canadian Medical Association Journal (CMAJ) today honoured eight outstanding Canadian individuals and teams with the first ever CIHR-CMAJ Top Canadian Achievements in Health Research Awards, which recognize and celebrate Canadian health research and innovation excellence.
Young people overwhelmingly support putting tobacco products out of sight in shops according to new research released today (Monday) by Cancer Research UK.
› Verified 1 days ago
Dr. Rene Recinos, M.D., PHD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5360 Fax: 641-494-5361 |